Skip to main content

Chemiluminescence of Polymorphonuclear Leukocytes in Response to Interferons

  • Conference paper
Cytokines in Hemopoiesis, Oncology, and AIDS
  • 60 Accesses

Abstract

Interest in the pleiotropic action of IFNs has focussed on their antiviral, antimitogenic and immunomodulatory activities [45, 47]. As IFNs express activity against several human malignancys, new possibilities for managing patients with cancer have been suggested and are under investigation [11, 20, 35, 36, 44]. Evidence was given that type I (leukocyte and fibroblast) and type II (γ) IFNs operate through independent receptor sites [5, 50] and induce alterations in cell membranes and in the cytoskelton [41, 33]. IFN-γ has been found in various systems to display greater antiproliferative effects and inhibition of CFU-GM than either IFN-α or IFN-β [4, 6, 12, 29].

Supported by Deutsche Forschungsgemeinschaft Ri 257/7-1

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Allen RC, Yevich SJ, Orth RW et al. (1974) The superoxide anion and singlet molecular oxygen:their role in the microbicidal activity of the polymorphonuclear leukocyte. Biochem Biophys Res Comm 60:909–917

    Article  PubMed  CAS  Google Scholar 

  2. Ball ED, Guyre PM, Shen L et al. (1984) Gamma interferon induces monocytoid differentiation in the HL-60 cell line. J Clin Invest 73:1072–1077

    Article  PubMed  CAS  Google Scholar 

  3. Berton G, Zeni L, Cassatella MA et al. (1986) Gamma interferon is able to enhance the oxidative metabolism of human neutrophils. Biochem Biophys Res Comm 138:1276–1283

    Article  PubMed  CAS  Google Scholar 

  4. Blalock JE, Georgiades JS, Langford MP et al. (1980) Pruified human interferon has more potent anticellular activity than fibroblast leukocyte interferon. Cell Immunol 49:390–397

    Article  PubMed  CAS  Google Scholar 

  5. Branca A, Baglioni C (1981) Evidence that type I and II IFNS have different receptors. Nature 294:768–770

    Article  PubMed  CAS  Google Scholar 

  6. Broxmeyer HE, Lu L, Platzer E et al. (1983) Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage ( CFU-GM) progenitor cells. J Immunol 131:1300–1307

    PubMed  CAS  Google Scholar 

  7. Brzoska J, Obert HJ (1987) Interferon gamma:Ein januskopfiger Mediator bei Entziin- dungen. Drug Res 37:1410–1416

    CAS  Google Scholar 

  8. Cassatella A, Capelli R, Bianca VD et al. (1988) Interferon-gamma activate human neutrophil oxygen metabolism and exocytosis. Immunology 63:499–506

    PubMed  CAS  Google Scholar 

  9. Djeu JY, Blanchard DK, Halkias D et al. (1986) Growth inhibition of Candida albicans by human polymorhonuclear neutrophils; activation by interferon-g and tumor necrosis factor. J Immunol 137:2980–2984

    PubMed  CAS  Google Scholar 

  10. Farr B, Gwalthney JM, Hayden FG et al. (1983) Human polymorphonuclear neutrophil functions are unaffected by human interferon alpha 2. Infect Immun 42:1195–1197

    PubMed  CAS  Google Scholar 

  11. Gutterman JU, Blumenschein GR, Alexanian R et al. (1980) Leukocyte interferon-induced tumor regression in human metastatic breast cancer, multiple myeloma, and malignant lymphoma. Ann Intern Med 93:399–406

    PubMed  CAS  Google Scholar 

  12. Gutterman JU, Fine S, Quesada J et al. (1982) Recombinant leukocyte A interferon:pharmacokinetics, single-dose tolerance, and biologic effects in cancer patients. Ann Intern Med 96:549–556

    PubMed  CAS  Google Scholar 

  13. Harris PE, Ralph P, Gabrilove J (1985) Distinct differentiation — inducing activities of gamma-interferon and cytokine factors acting on the human promyelocytic leukemia cell line HL-60. Cancer Res 45:3090–3095

    PubMed  CAS  Google Scholar 

  14. Harris PE, Ralph P, Litcofsky P (1985) Distinct activities of interferon-gamma, lymphokine and cytokine differention-inducing factors acting on the human monoblastoid leukemia cell line U 937. Cancer Res 45:9–13

    PubMed  CAS  Google Scholar 

  15. Hemmi H, Breitman TR (1987):Combinantion of recombinant human interferons and retinoic acid synergistically induce differentiation of the human promyelocytic leukemia cell line HL-60. Blood 60:501–507

    Google Scholar 

  16. Horan TD, English D, McPerson TA (1982) Association of neutrophil chemiluminescence with microbicidal activity. Clin Immunol Immunopathol 22:259–269

    Article  PubMed  CAS  Google Scholar 

  17. Huang KY, Donahoe RM, Gordon FB et al. (1971) Enchancement of phagocytosis by interferon-containing preparations. Infect Immun 4:581–541

    PubMed  CAS  Google Scholar 

  18. Ito M, Karmali R, Krim M (1985) Effect of interferon on chemiluminescence and hydroxyl radical production in murine macrophages stimulated by PMA. Immunology 56:533–541

    PubMed  CAS  Google Scholar 

  19. Kapp A, Kirchner H, Wokalek H et al. (1986):Modulation of Granulocyte oxidative response by recombinant interferon alpha 2 and gamma. Arch Dermatol Res 278:274–276

    Article  PubMed  CAS  Google Scholar 

  20. Kirkwood JM, Ernstoff MS (1984) Interferons in the treatment of human cancer. J Clin Oncol 2:336–342

    PubMed  CAS  Google Scholar 

  21. Kowanko IC, Ferrante A (1987) Stimulation of neutrophil respiratory burst and lysosomal enzyme release by human interferon gamma. Immunology 62:149–151

    PubMed  CAS  Google Scholar 

  22. Lee SHS, Epstein LB (1980) Reversible inhibition by interferon of the maturation of human peripheral blood monocytes to macrophages. Cell Immunol 50:177–190

    Article  PubMed  CAS  Google Scholar 

  23. Matsumoto S, Takei M, Moriyama M et al. (1987) Augmentation of antibody-dependent cellular cytotoxicity of polymorphonuclear leukocytes by interferon-gamma:mechanism dependent on enhancement of Fc receptor expression and increased release of activated oxygen. Chem Pharm Bull 35:1571–1578

    Article  PubMed  CAS  Google Scholar 

  24. Moritz T, Kirchner H (1986) The effect of interferons on cellular differentiation. Blut 53:361–370

    Article  PubMed  CAS  Google Scholar 

  25. Morrison CJ, Brummer E, Isenberg RA et al. (1987) Activation of murine polymorphonuclear neutrophils for fungicidal activity by recombinant gamma interferon. J Leuk Biol 41:434–440

    CAS  Google Scholar 

  26. Murphy P (1976):The neutrophil. Plenum, New York, p 17

    Google Scholar 

  27. Murray HW, Scavuzzo D, Jacobs JL et al. (1987):In vitro and in vivo activation of human monunclear phagocytes by interferon gamma. J Immunol 138:2457 - 2462

    PubMed  CAS  Google Scholar 

  28. Murray HW, Spitalny GL, Nathan CF (1985) Activation of mouse peritoneal macrophages in vitro and in vivo by interferon gamma. J Immunol 134:1619–1622

    PubMed  CAS  Google Scholar 

  29. Neumann HA, Fauser AA (1982) Effect of interferon on pluripotent hemopoietic progenitors ( CFU-GEMM) derived from human bone marrow, Exp Hematol 10:587–590

    PubMed  CAS  Google Scholar 

  30. Newburger PE, Dai O, Whitney C (1989) Regulation of phagocyte cytochrome b gene expression by lipopolysaccharides and cytokines, Pediat Res 25 (4/2):155A

    Google Scholar 

  31. Perussia B, Dayton ET, Lazarus et al. (1983) Immune interferon induces the receptor for monomeric IgGl on human monocytic and myeloid cells. J Exp Med 158:1092–1113

    Article  PubMed  CAS  Google Scholar 

  32. Perussia B, Kobayashi M, Rossi M et al. (1987) Immune interferon enhances functional properties of human granulocytes:role of Fc receptors and effect of lymphotoxin, tumor necrosis factor, and granulocyte-macrophage colony-stimulating factor J Immunol 138:765–774

    PubMed  CAS  Google Scholar 

  33. Pfeffer LM, Wang E, Tamm I (1980) Interferon effects on microfilament organization, cellular fibronectin distribution, and cell motility in human fibroblasts. J Cell Biol 85:9–17

    Article  PubMed  CAS  Google Scholar 

  34. Pure E, Luster AD, Unkeless JC (1984) Cell surface expression of murine, rat and human Fc receptors by XENOPUS oocytes. J Exp Med 160:606–611

    Article  PubMed  CAS  Google Scholar 

  35. Queseda JR, Reuben J, Manning JT et al. (1984) Alpha interferon for induction of remission in hairy cell leukemia. N Engl J Med 310:15–18

    Article  Google Scholar 

  36. Queseda JR, Swanson DA, Trindade A et al. (1983) Renal cell carcinoma:antitumor effects of leukocyte interferon. Cancer Res 43:940 - 943

    Google Scholar 

  37. Rister M, Burmeister K (1982) Superoxid-Dismutase und Super-oxid-Radikal Freisetzung bei juveniler rheumatoider Arthritis. Klin Wochenschr 60:561–565

    Article  PubMed  CAS  Google Scholar 

  38. Rister M, Suttorp M (1986) Iatrogene Granulozytenstorungen. Beitr Infusionstherap Klin Ernahr 15:268–276

    CAS  Google Scholar 

  39. Rosen H, Klebanoff SJ (1976) Chemiluminescence and superoxide production by myelo- peroxidase-deficient leukocytes. J Clin Invest 58:50–60

    Article  PubMed  CAS  Google Scholar 

  40. Schultz RM (1980) Macrophage activation by interferons. In:Pick E (ed) Lymphokine reports, vol 1. Academic. New York, pp 67–97

    Google Scholar 

  41. Sehgal P, Tamm LM, Tamm I (1982):Interferon and its inducers. In:Came PE, Caliguiri LA (eds) Chemotherapy of viral infections. Springer, Berlin Heidelberg New York, pp 205 - 221

    Chapter  Google Scholar 

  42. Steinbeck MJ, Roth JA, Kaeberle ML (1986) Activation of bovine neutrophils by recombinant interferon g. Cell Immunol 98:137 - 144

    Article  PubMed  CAS  Google Scholar 

  43. Suttorp M, Eymers B, Rister M (1987) Variations of granulocyte chemiluminescene induced by different stimuli during cancer therapy. In Mauri C, Rizzo SC, Ricevutti G (eds). The biology of phagocytes in health and disease. Pergamonn, Oxford, pp 207–214 Advances in the biosciences, vol 66

    Google Scholar 

  44. Talpaz M, Kantarjian HM, McCredie KB (1987) Clinical investigation of human alpha interferon in chronic myeolgenous leukiemia. Blood 69:1280–1288

    PubMed  CAS  Google Scholar 

  45. Taylor-Papadimitriou J (1980) Effects of interferons on cell growth and function. In:Interferon 1980, vol 2. Academic, New York, pp 435–442

    Google Scholar 

  46. Thon U, Gorl C, Kretschmer V et al. (1986) Chemilumineszenz von Granulozyten:Methodische Variable und Einflup von Rontgenbestrahlung auf Leukozytenpraparate. Beitr Infusionstherap Klin Ernah 15:253–267

    CAS  Google Scholar 

  47. Trinchieri G, Perussia B (1985) Immune interferon:a pleitoropic lymphokine with multiple effects. Immunology Today 6:131–135

    Article  CAS  Google Scholar 

  48. Uden AM, Hafstrom I, Palmblad J (1984) Effects of human interferon preparations on neutrophil functions. Acta Med Scand 216:179–186

    Article  PubMed  CAS  Google Scholar 

  49. Whitin JC, Ryan DH, Cohen HJ (1985) Graded responses of human neutrophils induced by serum-treated zymosan. Blood 66:1182–1188

    PubMed  CAS  Google Scholar 

  50. Zoon KC, Arnheiter H (1984) Studies on the interferon receptors. Pharmaco Ther 24:259–278

    Article  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer-Verlag, Berlin Heidelberg

About this paper

Cite this paper

Suttorp, M., Barzantny, U., Rister, M. (1990). Chemiluminescence of Polymorphonuclear Leukocytes in Response to Interferons. In: Freund, M., Link, H., Welte, K. (eds) Cytokines in Hemopoiesis, Oncology, and AIDS. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-75510-1_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-75510-1_10

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-52281-2

  • Online ISBN: 978-3-642-75510-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics